maklogo
Market Research Report

Global Intravenous Packaging Market Insights, Size, and Forecast By End Use (Hospitals, Ambulatory Surgical Centers, Home Healthcare), By Product Type (IV Bags, IV Bottles, IV Sets, IV Cannulas), By Material Type (Plastic, Glass, Rubber), By Application (Chemotherapy, Fluid Replacement, Nutritional Support, Medication Administration), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035

Report ID:59757
Published Date:Jan 2026
No. of Pages:212
Base Year for Estimate:2025
Format:
Customize Report

Key Market Insights

Global Intravenous Packaging Market is projected to grow from USD 14.8 Billion in 2025 to USD 25.9 Billion by 2035, reflecting a compound annual growth rate of 6.4% from 2026 through 2035. The intravenous packaging market encompasses the specialized containers and delivery systems used for administering medications, fluids, and nutrients directly into a patient's bloodstream. This includes a range of products designed to ensure sterility, compatibility with various drug formulations, and ease of use in clinical settings. Key drivers propelling this growth include the escalating prevalence of chronic diseases requiring long-term IV therapy, the increasing number of surgical procedures, and the expanding geriatric population, which often requires intravenous fluid and medication administration. Technological advancements in packaging materials, such as multi-layer films offering enhanced barrier properties and improved drug stability, are also significant contributors. Furthermore, the rising adoption of home healthcare settings for IV therapy is driving demand for user-friendly and safe packaging solutions.

Global Intravenous Packaging Market Value (USD Billion) Analysis, 2025-2035

maklogo
6.4%
CAGR from
2025 - 2035
Source:
www.makdatainsights.com

Among the various product types, IV Bags currently represent the leading segment, capturing the largest share of the market due to their versatility, cost-effectiveness, and widespread use across diverse medical applications. Important trends shaping the market include the growing emphasis on sustainable and eco-friendly packaging materials, leading to the development of recyclable and biodegradable options. There is also a strong move towards pre-filled syringes and ready-to-use IV solutions, which enhance patient safety by reducing medication errors and improving workflow efficiency for healthcare professionals. Another notable trend is the integration of smart packaging technologies, such as RFID tags and temperature sensors, to monitor product integrity and traceability throughout the supply chain. Despite the robust growth prospects, the market faces certain restraints, including stringent regulatory frameworks governing medical device and pharmaceutical packaging, which can lead to lengthy approval processes and high compliance costs. Additionally, the risk of needlestick injuries and the potential for contamination during IV administration pose ongoing challenges that the industry continuously addresses through improved designs and safety features.

North America currently holds the dominant position in the global intravenous packaging market, driven by its advanced healthcare infrastructure, high healthcare expenditure, strong presence of key pharmaceutical and medical device manufacturers, and early adoption of innovative medical technologies. The region also benefits from a large patient pool requiring intravenous therapies and a well-established regulatory environment that supports market expansion. Conversely, Asia Pacific is anticipated to be the fastest-growing region, fueled by the rapidly improving healthcare access, increasing disposable incomes, burgeoning medical tourism industry, and a substantial unmet medical need across populous nations like China and India. The expanding healthcare infrastructure and a growing focus on improving patient care standards in the region are also contributing factors. Key players in this market, including Draegerwerk AG, Smiths Medical, Sutures Medical, Hospira, C. R. Bard Inc., McKesson Corporation, Cardinal Health, Baxter International, Terumo Corporation, and Nipro Corporation, are strategically focusing on product innovation, geographic expansion, and collaborations to strengthen their market positions and capitalize on emerging opportunities. Their strategies often involve developing specialized packaging for high-potency drugs, investing in automated manufacturing processes, and forming partnerships with healthcare providers to offer integrated solutions.

Quick Stats

  • Market Size (2025):

    USD 14.8 Billion

  • Projected Market Size (2035):

    USD 25.9 Billion

  • Leading Segment:

    IV Bags (45.2% Share)

  • Dominant Region (2025):

    North America (36.8% Share)

  • CAGR (2026-2035):

    6.4%

Global Intravenous Packaging Market Emerging Trends and Insights

Sustainable Solutions Reshaping IV Packaging

Sustainable solutions are profoundly reshaping intravenous IV packaging, driven by a global shift towards environmental responsibility. Manufacturers are embracing innovative materials and designs to minimize ecological impact throughout the product lifecycle. This trend involves developing biobased plastics derived from renewable resources, reducing reliance on traditional fossil fuel dependent polymers. Furthermore, emphasis is placed on creating recyclable and compostable packaging alternatives that alleviate landfill burden. Light weighting strategies are also prevalent, decreasing material usage and transportation emissions. Additionally, companies are exploring closed loop systems for IV packaging, aiming to reuse or repurpose materials after use. The adoption of these sustainable practices not only addresses environmental concerns but also enhances corporate reputation and aligns with evolving consumer and healthcare provider preferences for eco friendly products.

Smart Packaging Innovations for Enhanced Patient Safety

Smart packaging innovations are transforming intravenous (IV) care, prioritizing patient safety through advanced features. These include intelligent labeling systems that prevent medication errors by verifying drug authenticity and dosage with scannable codes. Temperature and light sensitive indicators within the packaging alert healthcare professionals to compromised solutions, ensuring drug efficacy and reducing adverse reactions.

Additionally, tamper evident seals enhance security, visibly indicating any unauthorized access and safeguarding sterility. This technology extends to humidity control within packaging, protecting sensitive formulations. These innovations collectively minimize human error, prevent counterfeiting, and maintain product integrity throughout the supply chain, ultimately contributing to safer medication delivery and improved patient outcomes in hospitals and homecare settings.

Personalized Medicine Driving Adaptive IV Packaging

Personalized medicine's evolution significantly impacts intravenous packaging. As treatments become tailored to individual patient needs, so too must the delivery systems. This trend moves beyond one size fits all IV bags, demanding adaptable packaging solutions. Future IV packaging will feature modular designs, allowing for on demand customization of medication concentrations, admixtures, and fill volumes. Smart packaging technologies, like integrated sensors and RFID tags, will provide real time monitoring of drug integrity and patient specific infusion parameters. These advancements support precise dosing and prevent medication errors inherent in personalized regimens. The focus shifts to flexible formats that facilitate just in time preparation and minimize waste, ultimately enhancing patient safety and treatment efficacy in highly individualized healthcare scenarios.

What are the Key Drivers Shaping the Global Intravenous Packaging Market

Growing Prevalence of Chronic Diseases and Aging Population

The increasing global incidence of chronic diseases like diabetes, cancer, and heart conditions significantly fuels the demand for intravenous packaging. These long term illnesses often necessitate prolonged hospital stays, frequent medication delivery, and nutritional support, all of which rely heavily on IV administration. Concurrently, an aging global population contributes to this trend. Older individuals are more susceptible to multiple chronic conditions and often require more intensive medical care, including IV therapies for hydration, nutrition, and medication delivery. This demographic shift directly translates into a greater need for safe, effective, and readily available IV solutions and the packaging that contains them, driving substantial growth in the intravenous packaging market.

Advancements in Intravenous Packaging Technologies and Materials

Innovations in intravenous packaging are a significant market driver. These advancements focus on enhancing patient safety, improving drug stability, and increasing convenience for healthcare providers. New materials like multi layer plastics offer superior barrier properties, protecting sensitive medications from oxygen and moisture degradation. Improved designs, such as prefilled syringes and flexible bags, reduce preparation time and minimize contamination risks during drug administration. Tamper evident features and advanced sterilization techniques further enhance product integrity and patient confidence. These technological strides directly address critical healthcare needs, driving demand for more sophisticated and reliable intravenous packaging solutions across the globe.

Rising Demand for Home Healthcare and Infusion Therapy

A key driver for the intravenous packaging market is the significant rise in demand for home healthcare and infusion therapy. As populations age and chronic conditions become more prevalent, there is a growing preference for receiving medical care outside traditional hospital settings. Home healthcare offers convenience and comfort, enabling patients to recover or manage illnesses within their familiar environments. Infusion therapy, which delivers medications directly into the bloodstream, is increasingly being administered at home for conditions like infections, cancer, and dehydration. This shift necessitates a reliable supply of sterile and safe intravenous packaging, including bags, bottles, and accessories, to ensure the effective and secure delivery of these vital therapies in non-clinical settings.

Global Intravenous Packaging Market Restraints

Stringent Regulatory Approval Processes for Novel Packaging Materials

The introduction of innovative packaging materials in the global intravenous packaging market faces a significant hurdle: stringent regulatory approval processes. Manufacturers must navigate a complex and lengthy path to market for any new material. This involves extensive testing for biocompatibility, sterility, integrity, and chemical compatibility with various drug formulations. Each new material necessitates rigorous scientific data submission to regulatory bodies like the FDA or EMA. The evaluation period can span several years, requiring substantial investment in research and development, clinical trials, and documentation. This extended timeline and high cost of approval act as a strong deterrent for companies considering novel packaging solutions, slowing down innovation and limiting the adoption of potentially superior materials. The stringent nature ensures patient safety but inherently restricts market expansion by new packaging technologies.

High Capital Investment and Long Payback Periods for Sustainable Packaging Solutions

Developing sustainable intravenous packaging requires substantial upfront capital. Companies must invest in new materials, specialized manufacturing equipment, and potentially redesign entire production lines to accommodate eco friendly options. This significant initial outlay represents a high barrier to entry for many manufacturers. Furthermore the returns on these investments are not immediate. The transition to sustainable solutions involves extensive testing regulatory approvals and market acceptance which collectively contribute to protracted periods before profitability is realized. This extended payback timeframe coupled with the large initial expenditure makes sustainable packaging less attractive to some manufacturers who prioritize quicker returns on investment. The financial commitment and the delayed realization of benefits thus act as a substantial impediment to widespread adoption of greener packaging in the global intravenous market.

Global Intravenous Packaging Market Opportunities

Sustainable & High-Barrier IV Packaging for Enhanced Drug Stability

The opportunity for sustainable and high barrier IV packaging is significant, driven by crucial needs in drug stability and environmental stewardship. Modern intravenous therapies, especially sensitive biologics and complex drug formulations, require superior protection from oxygen, moisture, and light to maintain potency and extend shelf life. This enhanced drug stability directly improves patient safety and therapeutic efficacy globally. Concurrently, there is a powerful global demand for environmentally conscious solutions. Healthcare providers and regulatory bodies increasingly prioritize packaging that reduces ecological footprint without compromising drug integrity. Developing innovative materials that offer both excellent barrier properties and are biodegradable, recyclable, or from renewable sources presents a substantial competitive advantage. This dual focus addresses escalating demand for robust drug protection alongside the urgent need for greener healthcare practices, creating a lucrative segment for advanced packaging solutions that align with evolving pharmaceutical requirements and global sustainability goals.

Growth Opportunities in Ready-to-Use and Smart IV Packaging Solutions

Growth opportunities in intravenous packaging are significantly driven by ready-to-use and smart solutions. Ready-to-use packaging offers substantial benefits by pre filling and pre mixing medications, thereby eliminating manual preparation by healthcare professionals. This drastically reduces the risk of medication errors, improves patient safety, and enhances operational efficiency within healthcare facilities. The convenience and reliability these solutions provide are highly valued, leading to faster administration and reduced labor costs.

Concurrently, smart IV packaging presents another powerful growth avenue. These innovative solutions incorporate technologies for real time tracking of medication, precise temperature monitoring to ensure drug stability, and automated dosage verification. Such intelligent features enhance inventory management, optimize supply chain logistics, and provide critical safeguards against incorrect administration. The combined demand for these efficient, safe, and technologically advanced packaging solutions is creating a lucrative market for manufacturers globally.

Global Intravenous Packaging Market Segmentation Analysis

Key Market Segments

By Product Type

  • •IV Bags
  • •IV Bottles
  • •IV Sets
  • •IV Cannulas

By Material Type

  • •Plastic
  • •Glass
  • •Rubber

By Application

  • •Chemotherapy
  • •Fluid Replacement
  • •Nutritional Support
  • •Medication Administration

By End Use

  • •Hospitals
  • •Ambulatory Surgical Centers
  • •Home Healthcare

Segment Share By Product Type

Share, By Product Type, 2025 (%)

  • IV Bags
  • IV Bottles
  • IV Sets
  • IV Cannulas
maklogo
$14.8BGlobal Market Size, 2025
Source:
www.makdatainsights.com

Why are IV Bags the leading product type in the Global Intravenous Packaging Market?

IV Bags command a significant share due to their inherent advantages, offering superior flexibility, reduced risk of particulate contamination, and easier storage and disposal compared to rigid containers. Their lightweight nature and collapsibility also contribute to lower transportation costs and efficient use of hospital space. This preference is driven by both healthcare provider convenience and enhanced patient safety.

How do material types influence packaging choices within the Global Intravenous Packaging Market?

Material types are critical in determining suitability and safety. Plastic dominates due to its flexibility, durability, and cost effectiveness, widely used for IV bags and many bottles. Glass is chosen for specific medications requiring high chemical stability and barrier properties, often for more sensitive compounds. Rubber is essential for stoppers and seals, ensuring sterility and allowing multiple punctures for medication addition or withdrawal without compromising package integrity.

What key factors drive the demand for intravenous packaging across various end-use settings?

Demand is primarily fueled by the increasing prevalence of chronic diseases and the growing need for efficient medication delivery. Hospitals remain the largest end use, requiring a vast range of products for diverse treatments. Ambulatory Surgical Centers prioritize convenient and sterile solutions for shorter procedures, while Home Healthcare emphasizes user friendly, safe, and portable options that can be managed by patients or caregivers.

Global Intravenous Packaging Market Regulatory and Policy Environment Analysis

The global intravenous IV packaging market is heavily regulated, prioritizing patient safety and product integrity. Regulatory bodies such as the US FDA, European Medicines Agency EMA, and national health authorities enforce stringent guidelines on materials, manufacturing processes, and quality control. Regulations mandate biocompatibility, sterility assurance, container closure integrity, and minimal leachables to prevent drug contamination and ensure stability. Adherence to Good Manufacturing Practices GMP is critical throughout the supply chain. International standards like ISO 13485 for medical device quality management systems are widely adopted, promoting consistency. There is a growing emphasis on sustainable and recyclable packaging solutions, driving policy shifts towards environmentally friendly materials and waste management. Furthermore, labeling requirements are precise, ensuring clear identification and usage instructions. These evolving frameworks necessitate continuous innovation and compliance from packaging manufacturers. Harmonization efforts aim to standardize regulations globally, though regional variations persist, creating a complex but essential compliance landscape.

Which Emerging Technologies Are Driving New Trends in the Market?

Innovations in global intravenous packaging are transforming the market, driven by demands for enhanced patient safety, sustainability, and operational efficiency. Emerging technologies focus on advanced material science, introducing biodegradable polymers and lighter weight designs to significantly reduce environmental impact. Smart packaging solutions integrate sensors for temperature monitoring, integrity checks, and RFID for inventory management, ensuring product quality and traceability throughout the supply chain. New barrier technologies extend drug shelf life and protect sensitive formulations from light and oxygen degradation. Developments include multi chamber bags for simultaneous drug delivery and pre filled systems simplifying preparation and reducing medication errors. These advancements address critical healthcare needs, improving drug stability, ease of use for medical professionals, and overall supply chain security, propelling market evolution.

Global Intravenous Packaging Market Regional Analysis

Global Intravenous Packaging Market

Trends, by Region

Largest Market
Fastest Growing Market
maklogo
36.8%

North America Market
Revenue Share, 2025

Source:
www.makdatainsights.com

Dominant Region

North America · 36.8% share

North America dominates the Global Intravenous Packaging Market with a substantial 36.8% market share. This significant position is driven by several key factors. The region benefits from advanced healthcare infrastructure, readily adopting innovative packaging solutions. There is a high prevalence of chronic diseases requiring intravenous therapies, fueling demand for reliable and safe packaging. Furthermore, stringent regulatory frameworks ensure high quality standards for medical packaging, leading to a preference for specialized intravenous solutions. Major pharmaceutical and medical device companies headquartered in North America also contribute to the region's strong market presence through continuous research and development in packaging technologies.

Fastest Growing Region

Asia Pacific · 9.2% CAGR

Asia Pacific is poised to be the fastest growing region in the global intravenous packaging market, exhibiting a robust CAGR of 9.2% from 2026 to 2035. This significant expansion is driven by several converging factors. A rapidly increasing geriatric population across countries like China and India fuels demand for healthcare services and intravenous therapies. Furthermore, the rising prevalence of chronic diseases and a growing number of surgical procedures contribute to the heightened need for IV solutions and, consequently, their packaging. Continuous advancements in healthcare infrastructure and rising healthcare expenditure within the region further bolster this growth. The expanding pharmaceutical and biotechnology industries also play a pivotal role, driving innovation and adoption of advanced intravenous packaging solutions.

Impact of Geopolitical and Macroeconomic Factors

Geopolitically, supply chain resilience is paramount, with manufacturers diversifying sourcing to mitigate risks from regional conflicts and trade disputes. Dependencies on specific nations for raw materials like polymers or specialized films create vulnerabilities, prompting strategic shifts towards localized production and stockpiling. Regulatory harmonization or divergence, particularly concerning pharmaceutical packaging safety standards, significantly impacts market access and operational costs across different regions. Stricter environmental regulations, like those on plastic usage, could accelerate the adoption of more sustainable and biodegradable packaging solutions, driving innovation and potentially higher costs.

Macroeconomically, global inflation pressures are impacting manufacturing costs, including energy, raw materials, and labor, potentially leading to higher product prices for intravenous packaging. Economic slowdowns in key markets could reduce hospital procedure volumes, indirectly affecting demand. Conversely, increasing healthcare expenditures, especially in emerging economies driven by expanding populations and improving access to medical care, will continue to fuel market growth. Exchange rate fluctuations also play a critical role, influencing the profitability of international trade and investment decisions for packaging manufacturers.

Recent Developments

  • March 2025

    Baxter International announced a strategic initiative to invest heavily in smart IV packaging technologies. This includes integrating RFID tags and advanced data matrix codes into their primary IV solution bags to enhance traceability and reduce medication errors in hospital settings.

  • November 2024

    Terumo Corporation launched a new line of PVC-free and DEHP-free IV bags designed for specialized drug delivery. This product launch addresses the growing demand for safer and environmentally friendlier packaging options, particularly for sensitive medications and pediatric patients.

  • September 2024

    Smiths Medical formed a partnership with a leading biopharmaceutical company to co-develop innovative pre-filled syringe and IV bag systems for complex biologics. This collaboration aims to provide ready-to-administer drug solutions, streamlining preparation and administration in clinical environments.

  • February 2025

    Cardinal Health completed the acquisition of a European manufacturer specializing in blow-fill-seal (BFS) technology for sterile liquid packaging. This acquisition strengthens Cardinal Health's manufacturing capabilities for single-dose IV solutions and expands its footprint in the European market.

Key Players Analysis

Draegerwerk AG and Baxter International are key players in the Global Intravenous Packaging Market, offering diverse technologies like pre filled syringes and flexible bags. Smiths Medical and Terumo Corporation focus on advanced infusion sets and smart pump systems. Strategic initiatives include collaborations and product launches by companies like Hospira and Cardinal Health, driven by increasing demand for home healthcare and patient safety innovations.

List of Key Companies:

  1. Draegerwerk AG
  2. Smiths Medical
  3. Sutures Medical
  4. Hospira
  5. C. R. Bard Inc.
  6. McKesson Corporation
  7. Cardinal Health
  8. Baxter International
  9. Terumo Corporation
  10. Nipro Corporation
  11. Amgen Inc.
  12. Vygon SA
  13. Medline Industries
  14. Fresenius Kabi
  15. B. Braun Melsungen
  16. Eagle Pharmaceuticals

Report Scope and Segmentation

Report ComponentDescription
Market Size (2025)USD 14.8 Billion
Forecast Value (2035)USD 25.9 Billion
CAGR (2026-2035)6.4%
Base Year2025
Historical Period2020-2025
Forecast Period2026-2035
Segments Covered
  • By Product Type:
    • •IV Bags
    • •IV Bottles
    • •IV Sets
    • •IV Cannulas
  • By Material Type:
    • •Plastic
    • •Glass
    • •Rubber
  • By Application:
    • •Chemotherapy
    • •Fluid Replacement
    • •Nutritional Support
    • •Medication Administration
  • By End Use:
    • •Hospitals
    • •Ambulatory Surgical Centers
    • •Home Healthcare
Regional Analysis
  • North America
  • • United States
  • • Canada
  • Europe
  • • Germany
  • • France
  • • United Kingdom
  • • Spain
  • • Italy
  • • Russia
  • • Rest of Europe
  • Asia-Pacific
  • • China
  • • India
  • • Japan
  • • South Korea
  • • New Zealand
  • • Singapore
  • • Vietnam
  • • Indonesia
  • • Rest of Asia-Pacific
  • Latin America
  • • Brazil
  • • Mexico
  • • Rest of Latin America
  • Middle East and Africa
  • • South Africa
  • • Saudi Arabia
  • • UAE
  • • Rest of Middle East and Africa

Table of Contents:

1. Introduction
1.1. Objectives of Research
1.2. Market Definition
1.3. Market Scope
1.4. Research Methodology
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Market Factor Analysis
4.1. Porter's Five Forces Model Analysis
4.1.1. Rivalry among Existing Competitors
4.1.2. Bargaining Power of Buyers
4.1.3. Bargaining Power of Suppliers
4.1.4. Threat of Substitute Products or Services
4.1.5. Threat of New Entrants
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic & Social Factors
4.2.3. Technological Factors
4.2.4. Environmental Factors
4.2.5. Legal Factors
4.3. Supply and Value Chain Assessment
4.4. Regulatory and Policy Environment Review
4.5. Market Investment Attractiveness Index
4.6. Technological Innovation and Advancement Review
4.7. Impact of Geopolitical and Macroeconomic Factors
4.8. Trade Dynamics: Import-Export Assessment (Where Applicable)
5. Global Intravenous Packaging Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
5.1. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
5.1.1. IV Bags
5.1.2. IV Bottles
5.1.3. IV Sets
5.1.4. IV Cannulas
5.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
5.2.1. Plastic
5.2.2. Glass
5.2.3. Rubber
5.3. Market Analysis, Insights and Forecast, 2020-2035, By Application
5.3.1. Chemotherapy
5.3.2. Fluid Replacement
5.3.3. Nutritional Support
5.3.4. Medication Administration
5.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
5.4.1. Hospitals
5.4.2. Ambulatory Surgical Centers
5.4.3. Home Healthcare
5.5. Market Analysis, Insights and Forecast, 2020-2035, By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia-Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
6. North America Intravenous Packaging Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
6.1. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
6.1.1. IV Bags
6.1.2. IV Bottles
6.1.3. IV Sets
6.1.4. IV Cannulas
6.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
6.2.1. Plastic
6.2.2. Glass
6.2.3. Rubber
6.3. Market Analysis, Insights and Forecast, 2020-2035, By Application
6.3.1. Chemotherapy
6.3.2. Fluid Replacement
6.3.3. Nutritional Support
6.3.4. Medication Administration
6.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
6.4.1. Hospitals
6.4.2. Ambulatory Surgical Centers
6.4.3. Home Healthcare
6.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
6.5.1. United States
6.5.2. Canada
7. Europe Intravenous Packaging Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
7.1. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
7.1.1. IV Bags
7.1.2. IV Bottles
7.1.3. IV Sets
7.1.4. IV Cannulas
7.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
7.2.1. Plastic
7.2.2. Glass
7.2.3. Rubber
7.3. Market Analysis, Insights and Forecast, 2020-2035, By Application
7.3.1. Chemotherapy
7.3.2. Fluid Replacement
7.3.3. Nutritional Support
7.3.4. Medication Administration
7.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
7.4.1. Hospitals
7.4.2. Ambulatory Surgical Centers
7.4.3. Home Healthcare
7.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
7.5.1. Germany
7.5.2. France
7.5.3. United Kingdom
7.5.4. Spain
7.5.5. Italy
7.5.6. Russia
7.5.7. Rest of Europe
8. Asia-Pacific Intravenous Packaging Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
8.1. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
8.1.1. IV Bags
8.1.2. IV Bottles
8.1.3. IV Sets
8.1.4. IV Cannulas
8.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
8.2.1. Plastic
8.2.2. Glass
8.2.3. Rubber
8.3. Market Analysis, Insights and Forecast, 2020-2035, By Application
8.3.1. Chemotherapy
8.3.2. Fluid Replacement
8.3.3. Nutritional Support
8.3.4. Medication Administration
8.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
8.4.1. Hospitals
8.4.2. Ambulatory Surgical Centers
8.4.3. Home Healthcare
8.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. New Zealand
8.5.6. Singapore
8.5.7. Vietnam
8.5.8. Indonesia
8.5.9. Rest of Asia-Pacific
9. Latin America Intravenous Packaging Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
9.1. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
9.1.1. IV Bags
9.1.2. IV Bottles
9.1.3. IV Sets
9.1.4. IV Cannulas
9.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
9.2.1. Plastic
9.2.2. Glass
9.2.3. Rubber
9.3. Market Analysis, Insights and Forecast, 2020-2035, By Application
9.3.1. Chemotherapy
9.3.2. Fluid Replacement
9.3.3. Nutritional Support
9.3.4. Medication Administration
9.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Centers
9.4.3. Home Healthcare
9.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East and Africa Intravenous Packaging Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
10.1. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
10.1.1. IV Bags
10.1.2. IV Bottles
10.1.3. IV Sets
10.1.4. IV Cannulas
10.2. Market Analysis, Insights and Forecast, 2020-2035, By Material Type
10.2.1. Plastic
10.2.2. Glass
10.2.3. Rubber
10.3. Market Analysis, Insights and Forecast, 2020-2035, By Application
10.3.1. Chemotherapy
10.3.2. Fluid Replacement
10.3.3. Nutritional Support
10.3.4. Medication Administration
10.4. Market Analysis, Insights and Forecast, 2020-2035, By End Use
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Home Healthcare
10.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
10.5.1. South Africa
10.5.2. Saudi Arabia
10.5.3. UAE
10.5.4. Rest of Middle East and Africa
11. Competitive Analysis and Company Profiles
11.1. Market Share of Key Players
11.1.1. Global Company Market Share
11.1.2. Regional/Sub-Regional Company Market Share
11.2. Company Profiles
11.2.1. Draegerwerk AG
11.2.1.1. Business Overview
11.2.1.2. Products Offering
11.2.1.3. Financial Insights (Based on Availability)
11.2.1.4. Company Market Share Analysis
11.2.1.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.1.6. Strategy
11.2.1.7. SWOT Analysis
11.2.2. Smiths Medical
11.2.2.1. Business Overview
11.2.2.2. Products Offering
11.2.2.3. Financial Insights (Based on Availability)
11.2.2.4. Company Market Share Analysis
11.2.2.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.2.6. Strategy
11.2.2.7. SWOT Analysis
11.2.3. Sutures Medical
11.2.3.1. Business Overview
11.2.3.2. Products Offering
11.2.3.3. Financial Insights (Based on Availability)
11.2.3.4. Company Market Share Analysis
11.2.3.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.3.6. Strategy
11.2.3.7. SWOT Analysis
11.2.4. Hospira
11.2.4.1. Business Overview
11.2.4.2. Products Offering
11.2.4.3. Financial Insights (Based on Availability)
11.2.4.4. Company Market Share Analysis
11.2.4.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.4.6. Strategy
11.2.4.7. SWOT Analysis
11.2.5. C. R. Bard Inc.
11.2.5.1. Business Overview
11.2.5.2. Products Offering
11.2.5.3. Financial Insights (Based on Availability)
11.2.5.4. Company Market Share Analysis
11.2.5.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.5.6. Strategy
11.2.5.7. SWOT Analysis
11.2.6. McKesson Corporation
11.2.6.1. Business Overview
11.2.6.2. Products Offering
11.2.6.3. Financial Insights (Based on Availability)
11.2.6.4. Company Market Share Analysis
11.2.6.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.6.6. Strategy
11.2.6.7. SWOT Analysis
11.2.7. Cardinal Health
11.2.7.1. Business Overview
11.2.7.2. Products Offering
11.2.7.3. Financial Insights (Based on Availability)
11.2.7.4. Company Market Share Analysis
11.2.7.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.7.6. Strategy
11.2.7.7. SWOT Analysis
11.2.8. Baxter International
11.2.8.1. Business Overview
11.2.8.2. Products Offering
11.2.8.3. Financial Insights (Based on Availability)
11.2.8.4. Company Market Share Analysis
11.2.8.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.8.6. Strategy
11.2.8.7. SWOT Analysis
11.2.9. Terumo Corporation
11.2.9.1. Business Overview
11.2.9.2. Products Offering
11.2.9.3. Financial Insights (Based on Availability)
11.2.9.4. Company Market Share Analysis
11.2.9.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.9.6. Strategy
11.2.9.7. SWOT Analysis
11.2.10. Nipro Corporation
11.2.10.1. Business Overview
11.2.10.2. Products Offering
11.2.10.3. Financial Insights (Based on Availability)
11.2.10.4. Company Market Share Analysis
11.2.10.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.10.6. Strategy
11.2.10.7. SWOT Analysis
11.2.11. Amgen Inc.
11.2.11.1. Business Overview
11.2.11.2. Products Offering
11.2.11.3. Financial Insights (Based on Availability)
11.2.11.4. Company Market Share Analysis
11.2.11.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.11.6. Strategy
11.2.11.7. SWOT Analysis
11.2.12. Vygon SA
11.2.12.1. Business Overview
11.2.12.2. Products Offering
11.2.12.3. Financial Insights (Based on Availability)
11.2.12.4. Company Market Share Analysis
11.2.12.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.12.6. Strategy
11.2.12.7. SWOT Analysis
11.2.13. Medline Industries
11.2.13.1. Business Overview
11.2.13.2. Products Offering
11.2.13.3. Financial Insights (Based on Availability)
11.2.13.4. Company Market Share Analysis
11.2.13.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.13.6. Strategy
11.2.13.7. SWOT Analysis
11.2.14. Fresenius Kabi
11.2.14.1. Business Overview
11.2.14.2. Products Offering
11.2.14.3. Financial Insights (Based on Availability)
11.2.14.4. Company Market Share Analysis
11.2.14.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.14.6. Strategy
11.2.14.7. SWOT Analysis
11.2.15. B. Braun Melsungen
11.2.15.1. Business Overview
11.2.15.2. Products Offering
11.2.15.3. Financial Insights (Based on Availability)
11.2.15.4. Company Market Share Analysis
11.2.15.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.15.6. Strategy
11.2.15.7. SWOT Analysis
11.2.16. Eagle Pharmaceuticals
11.2.16.1. Business Overview
11.2.16.2. Products Offering
11.2.16.3. Financial Insights (Based on Availability)
11.2.16.4. Company Market Share Analysis
11.2.16.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.16.6. Strategy
11.2.16.7. SWOT Analysis

List of Figures

List of Tables

Table 1: Global Intravenous Packaging Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 2: Global Intravenous Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 3: Global Intravenous Packaging Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 4: Global Intravenous Packaging Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 5: Global Intravenous Packaging Market Revenue (USD billion) Forecast, by Region, 2020-2035

Table 6: North America Intravenous Packaging Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 7: North America Intravenous Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 8: North America Intravenous Packaging Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 9: North America Intravenous Packaging Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 10: North America Intravenous Packaging Market Revenue (USD billion) Forecast, by Country, 2020-2035

Table 11: Europe Intravenous Packaging Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 12: Europe Intravenous Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 13: Europe Intravenous Packaging Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 14: Europe Intravenous Packaging Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 15: Europe Intravenous Packaging Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 16: Asia Pacific Intravenous Packaging Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 17: Asia Pacific Intravenous Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 18: Asia Pacific Intravenous Packaging Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 19: Asia Pacific Intravenous Packaging Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 20: Asia Pacific Intravenous Packaging Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 21: Latin America Intravenous Packaging Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 22: Latin America Intravenous Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 23: Latin America Intravenous Packaging Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 24: Latin America Intravenous Packaging Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 25: Latin America Intravenous Packaging Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 26: Middle East & Africa Intravenous Packaging Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 27: Middle East & Africa Intravenous Packaging Market Revenue (USD billion) Forecast, by Material Type, 2020-2035

Table 28: Middle East & Africa Intravenous Packaging Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 29: Middle East & Africa Intravenous Packaging Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 30: Middle East & Africa Intravenous Packaging Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Frequently Asked Questions

Industry

Packaging Transport Market Research

Explore comprehensive market research reports covering all aspects of the Packaging Transport industry, including market size, growth trends, competitive landscape, and strategic insights.

View Industry Page
;